Variable | Statistics | Effect size HR(95%CI) | P value |
---|---|---|---|
Age(years) | 67.352 ± 13.558 | 0.992 (0.983, 1.001) | 0.07672 |
Gender | |||
 Male | 670 (69.647%) | 1.0 |  |
 Female | 292 (30.353%) | 1.064 (0.816, 1.385) | 0.64813 |
Etiology of CKD | |||
 Diabetic nephropathy, | 244 (25.364%) | 1.0 |  |
 Nephrosclerosis, | 385 (40.021%) | 0.185 (0.136, 0.254) |  < 0.00001 |
 Glomerulonephritis | 178 (18.503%) | 0.295 (0.208, 0.419) |  < 0.00001 |
 Other | 155 (16.112%) | 0.174 (0.110, 0.277) |  < 0.00001 |
 BMI(kg/m2) | 23.756 ± 4.072 | 1.027 (0.995, 1.059) | 0.09929 |
 SBP(mmHg) | 139.388 ± 21.853 | 1.017 (1.012, 1.022) |  < 0.00001 |
 HB(g/dL) | 12.055 ± 2.213 | 0.691 (0.651, 0.733) |  < 0.00001 |
 Scr(mg/dL) | 2.144 ± 1.469 | 1.449 (1.396, 1.505) |  < 0.00001 |
 eGFR (ml/min per 1.73 m2) | 33.037 ± 18.007 | 0.917 (0.906, 0.929) |  < 0.00001 |
 ALB(g/dL) | 3.874 ± 0.605 | 0.349 (0.299, 0.407) |  < 0.00001 |
Urinary occult blood | |||
 No | 652 (67.775%) | 1.0 |  |
 Yes | 310 (32.225%) | 1.658 (1.290, 2.130) | 0.00008 |
 UPCR(g/gCr) | 2.037 ± 3.189 | 1.208 (1.183, 1.234) |  < 0.00001 |
Hypertension | |||
 No | 96 (9.979%) | 1.0 |  |
 Yes | 866 (90.021%) | 4.070 (1.920, 8.627) | 0.00025 |
History of CVD | |||
 No | 704 (73.181%) | 1.0 |  |
 Yes | 258 (26.819%) | 1.262 (0.962, 1.655) | 0.09277 |
Diabetes | |||
 No | 598 (62.162%) | 1.0 |  |
 Yes | 364 (37.838%) | 2.699 (2.101, 3.466) |  < 0.00001 |
Use of RAAS inhibitor | |||
 No | 336 (34.927%) | 1.0 |  |
 Yes | 626 (65.073%) | 1.727 (1.293, 2.308) | 0.00022 |
Use of calcium channel blocker | |||
 No | 503 (52.287%) | 1.0 |  |
 Yes | 459 (47.713%) | 1.724 (1.338, 2.221) | 0.00002 |
Use of diuretics | |||
 No | 650 (67.568%) | 1.0 |  |
 Yes | 312 (32.432%) | 2.197 (1.715, 2.815) |  < 0.00001 |